Test Directory
| Test Code | |||||||||||||||||||||||||
| PCRTB | |||||||||||||||||||||||||
| Test Name | |||||||||||||||||||||||||
| Mycobacterium Complex DNA PCR | |||||||||||||||||||||||||
| CPT Codes | |||||||||||||||||||||||||
| 87556 | |||||||||||||||||||||||||
| Expected Turnaround Time | |||||||||||||||||||||||||
| 1 - 3 days | |||||||||||||||||||||||||
| Clinical Utility | |||||||||||||||||||||||||
|
Used for rapid detection of M. tuberculosis, when used in conjunction with mycobacterial culture. This test does not provide rifampin resistance information and is most useful for non-sputum specimens. This test should not be used to determine bacteriologic cure or to monitor response to therapy. This test is not intended for the detection of latent tuberculosis and must not be used as a substitute for tests intended for detection of latent tuberculosis such as the tuberculin skin test or an interferon gamma release assay. |
|||||||||||||||||||||||||
| Specimen and Container Info | |||||||||||||||||||||||||
|
|||||||||||||||||||||||||
| Collection Instructions | |||||||||||||||||||||||||
|
|||||||||||||||||||||||||
| Processing and Submission Instructions | |||||||||||||||||||||||||
|
|||||||||||||||||||||||||
| Transport Instructions | |||||||||||||||||||||||||
|
Transport to the laboratory refrigerated. |
|||||||||||||||||||||||||
| Stability Requirements | |||||||||||||||||||||||||
|
|||||||||||||||||||||||||
| Causes for Rejection | |||||||||||||||||||||||||
|
|||||||||||||||||||||||||
| Methodology | |||||||||||||||||||||||||
| Real Time Polymerase Chain Reaction | |||||||||||||||||||||||||
| Reference Intervals | |||||||||||||||||||||||||
|
See patient report. |
|||||||||||||||||||||||||
| Limitations | |||||||||||||||||||||||||
|
Specimen volumes less than indicated may decrease sensitivity of testing. This rapid PCR assay detects Mycobacterium tuberculosis complex nucleic acid and, therefore, does not distinguish between viable, disease-related organisms and nucleic acid persisting from prior infection. Test results should be correlated with patient symptoms and clinical presentation before a definitive diagnosis is made. A negative result does not rule out the presence of M tuberculosis complex or active disease because the organism may be present at levels below the limit of detection for this assay. The sensitivity of this test with stool specimens is 80% and testing of additional stool specimens should be considered if the result from the first specimen is negative. |
|||||||||||||||||||||||||
| Reference Lab | |||||||||||||||||||||||||
| Mayo Clinic Laboratories | |||||||||||||||||||||||||
| Testing Schedule | |||||||||||||||||||||||||
| Routine, daily | |||||||||||||||||||||||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.